Our free daily oncology focused e-news service.
Subscribe» | Search Archives»
(Reuters) Dec 18, 2014 - AstraZeneca's all-important cancer drug business received a fillip on Thursday as a new medicine against ovarian cancer was approved in Europe, making it the first of its kind to reach the market.
read article »
(Wall Street Journal) Dec 18, 2014 - Merck & Co. acquired privately held OncoEthix for up to $375 million, its latest push into the oncology market as the pharmaceutical giant continues bolstering its research-and-development pipeline.
read article (paid subscription required) »
News Story Commentary By Academic and Community Oncologists
Learn more about the OBR training platform, developed to provide an in-depth understanding of the unique business dynamics of today's oncology landscape.
OBR Job Board
NCCN has posted 1 new job.
Bayer Biopharmaceuticals, Inc. has posted 20 jobs.
Ipsen Biopharmaceuticals, Inc. has posted over 50 jobs.